Contact this trialFirst, we need to learn more about you.
PARP Inhibitor
Niraparib for Brain Cancer
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing niraparib, a drug that may help treat cancer that has spread to the brain and spinal cord. It works by preventing cancer cells from fixing their damaged DNA, which can help kill them. The study will include about 20 participants and will last for a significant period. Niraparib is an oral drug approved for maintenance treatment in various cancers including ovarian cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service